L 230 (Hydrochlorothiazide and metoprolol tartrate 25 mg / 50 mg)
Pill imprint L 230 has been identified as Hydrochlorothiazide and metoprolol tartrate 25 mg / 50 mg.
Hydrochlorothiazide/metoprolol is used in the treatment of high blood pressure and belongs to the drug class beta blockers with thiazides. Risk cannot be ruled out during pregnancy. Hydrochlorothiazide/metoprolol 25 mg / 50 mg is not a controlled substance under the Controlled Substance Act (CSA).
More about hydrochlorothiazide/metoprolol
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 0 Reviews – Add your own review/rating
- Drug class: beta blockers with thiazides
- Metoprolol/hydrochlorothiazide extended-release tablets
- Hydrochlorothiazide and metoprolol
- Metoprolol and hydrochlorothiazide (Advanced Reading)
- Metoprolol Succinate and Hydrochlorothiazide (FDA)
- Metoprolol and Hydrochlorothiazide (FDA)
- Metoprolol and Hydrochlorothiazide (Wolters Kluwer)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.